Characteristics of the patients who developed tuberculosis in chisinau in 2015
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
243 0
SM ISO690:2012
LESNIK, Evelina; NIGULYANU, Adriana; MALIK, Alina; YAVORSKIY, Konstantin. Characteristics of the patients who developed tuberculosis in chisinau in 2015. In: Tuberculosis and Lung Diseases. 2018, nr. 7(96), pp. 46-49. ISSN 2075-1230.
EXPORT metadate:
Google Scholar
Dublin Core
Tuberculosis and Lung Diseases
Numărul 7(96) / 2018 / ISSN 2075-1230

Characteristics of the patients who developed tuberculosis in chisinau in 2015

Характеристика больных, заболевших туберкулезом, в г. Кишинэу в 2015 г.

DOI: 10.21292/2075-1230-2018-96-7-46-49
Pag. 46-49

Lesnik Evelina, Nigulyanu Adriana, Malik Alina, Yavorskiy Konstantin
”Nicolae Testemițanu” State University of Medicine and Pharmacy
Disponibil în IBN: 11 decembrie 2018


The objective of the study: to characterize patients who developed tuberculosis in Chisinau in 2015. Subjects and methods. The retrospective descriptive study was conducted aimed to analyze data of 668 tuberculosis patients diagnosed in Chisinau in 2015. Results. The social characteristics demonstrated that in 2015 in Chisinau a tuberculosis patient was most often a young man belonging to socially marginalized population with no medical insurance. The analysis of tuberculosis detection methods showed that only 22.3% of patients were detected through regular screening in risk groups. Among tuberculosis patients, new cases made 60.3%, relapses - 21.7%, those after treatment interruption - 10.3%, and those after treatment failure - 5.7%. In 14 (2.0%) patients, tuberculosis was detected post-mortem. Out of 674 patients with life time diagnosed tuberculosis, pulmonary tuberculosis prevailed - 638 (94.7%), of them, 193 (30.3%) had a positive result of sputum microscopy for acid-fast bacilli, and 187 (29.3%) patients had a positive result of sputum culture by Lowenstein-Jensen or Bactec 960, and the result of Xpert MTB/Rif was positive in 259 (40.6%) patients. Multiple drug resistance was diagnosed in 118/187 (63.1%) patients. In 12 months, treatment outcomes were assessed in 647 patients: treatment was successful in 393 (60.7%) patients; 80 (12.4%) patients died, and 174 (26.9%) were still on treatment.

Detection methods, Microbiological parameters, Social characteristics, Treatment outcomes,